Literature DB >> 988549

Norepinephrine and isoprenaline induced changes of peripheral blood flow acceleration caused by changes of cardiac inotropy.

W F Immink, H J Beijer, F A Brouwer, G A Charbon.   

Abstract

In anesthetized dogs the norepinephrine (NE) and isoprenaline (ISO) (1--1024 ng/kg i.v.)--induced increase of maximum peripheral flow acceleration (celiac artery, cranial mesenteric artery, renal artery; and femoral artery) and the changes of the maximum first derivative of arterial pressure were compared with the increases of maximum ascending aortic flow acceleration and maximum first derivative of left ventricle pressure (LV dP/dt max). The maximum effect of each dose on maximum acceleration of flows (dF/dt max) and maximum first derivative of pressures (dP/dt max) occurred simultaneously for all v56--512 ng/kg) and for ISO (D50:128--256) ng/kg). We demonstrated that other varure) played only a minor role in the increases of LV dP/dt max in our studies. In contrast with the uniform response of dF/dt max and dP/dt max, the reaction of peripheral vascular resistance varied. In particular in the gastrointestinal tract the resistance could either be increased (NE, D50:115 ng/kg) or decreases (ISO, D50:15 ng/kg). Gastrointestinal resistance was a more sensitive variable for catecholamine stimulation than dF/dt max and dP/dt max. The data show that under the present experimental conditions induced by NE and ISO is due to increase of cardiac inotropy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 988549     DOI: 10.1007/bf01067008

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  17 in total

1.  THE DETERMINANTS OF THE RATE OF CHANGE OF THE LEFT VENTRICULAR PRESSURE (DP/DT).

Authors:  W K SCHAPER; P LEWI; A H JAGENEAU
Journal:  Arch Kreislaufforsch       Date:  1965-03

2.  INITIAL VENTRICULAR IMPULSE. A POTENTIAL KEY TO CARDIAC EVALUATION.

Authors:  R F RUSHMER
Journal:  Circulation       Date:  1964-02       Impact factor: 29.690

3.  Hemodynamic determinants of the maximal rate of rise of left ventricular pressure.

Authors:  A G WALLACE; N S SKINNER; J H MITCHELL
Journal:  Am J Physiol       Date:  1963-07

4.  The hemodynamic determinants of the rate of change in pressure in the left ventricle during isometric contraction.

Authors:  T J REEVES; L L HEFNER; W B JONES; C COGHLAN; G PRIETO; J CARROLL
Journal:  Am Heart J       Date:  1960-11       Impact factor: 4.749

5.  The effect of haemodynamic changes on maximum blood flow acceleration at the aortic root in the anaesthetized, open-chest dog.

Authors:  D C Chung; J H Chamberlain; R G Seed
Journal:  Cardiovasc Res       Date:  1974-05       Impact factor: 10.787

6.  In vivo comparison of electromagnetic and Doppler flowmeters: with special attention to the processing of the analogue Doppler flow signal.

Authors:  R S Reneman; H F Clarke; N Simmons; M P Spencer
Journal:  Cardiovasc Res       Date:  1973-07       Impact factor: 10.787

7.  In vivo comparison of catheter manometer systems with the catheter-tip micromanometer.

Authors:  K L Gould; S Trenholme; J W Kennedy
Journal:  J Appl Physiol       Date:  1973-02       Impact factor: 3.531

8.  Effect of noradrenaline and isoprenaline on pulsatile hemodynamics.

Authors:  E E Pieper; R S Reneman; G A Charbon
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-12

9.  Problems in the use of indices of myocardial contractility.

Authors:  G C Van den Bos; C Elzinga; N Westerhof; M I Noble
Journal:  Cardiovasc Res       Date:  1973-11       Impact factor: 10.787

10.  [Velocity of pressure rise in the left ventricle as criterion of contractility under different hemodynamic conditions].

Authors:  C Morgenstern; G Arnold; U Höljes; W Lochner
Journal:  Pflugers Arch       Date:  1970       Impact factor: 3.657

View more
  1 in total

1.  Hemodynamic effects of norepinephrine and isoprenaline in various regions of the canine splanchnic area.

Authors:  W F Immink; H J Beijer; G A Charbon
Journal:  Pflugers Arch       Date:  1976-09-30       Impact factor: 3.657

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.